Enterprise artificial intelligence firm C3.ai has experienced a punishing year, with its shares plummeting more than 65% since January. However, a surprising trend has emerged just ahead of critical quarterly earnings: major institutional investors appear to be using the depressed price levels to establish positions. Are seasoned professionals betting on an imminent recovery, or are they mistakenly catching a falling knife?
Microsoft Partnership Fuels Optimism
A significant catalyst behind the renewed positive sentiment stems from the strengthened strategic alliance with Microsoft. On November 20, the companies announced deeper integration of C3.ai applications within the Microsoft ecosystem, including Copilot and Azure services.
This collaboration represents far more than a technical enhancement for C3.ai. Access to Microsoft’s vast global sales network could provide the crucial leverage needed to overcome the company’s recently criticized growth challenges. Market participants anticipate this partnership will substantially accelerate market adoption of C3.ai’s enterprise AI solutions.
Institutional Investor Makes Significant Move
While many retail investors have capitulated following the prolonged downtrend, so-called “smart money” appears to be accumulating shares. Geode Capital Management has substantially increased its holdings, acquiring approximately 156,000 additional shares. This transaction elevates the asset manager’s total stake to over 2.8 million company shares.
Should investors sell immediately? Or is it worth buying C3.ai?
This move carries considerable significance as it occurs during a period of extreme price weakness. The stock currently trades more than 71% below its 52-week peak. That institutional managers are expanding their exposure at this juncture suggests a calculated wager on long-term recovery, despite the discrepancy between the original carrying value and the current, substantially lower market valuation.
December Earnings: The Critical Test
Despite these encouraging signals from the investment community, the situation remains highly charged. The company faces its ultimate turnaround test on Wednesday, December 3, 2025, when it discloses second-quarter financial results after market close.
Market sentiment currently reflects nervous anticipation. Although the share price has recently edged slightly above its 52-week low of €11.15, elevated volatility and an RSI reading exceeding 75 warrant caution. Whether the institutional accumulation proves prescient or the Microsoft alliance provides merely temporary relief will become evident within days. Investors should prepare for potentially turbulent trading sessions ahead.
Ad
C3.ai Stock: Buy or Sell?! New C3.ai Analysis from November 25 delivers the answer:
The latest C3.ai figures speak for themselves: Urgent action needed for C3.ai investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 25.
C3.ai: Buy or sell? Read more here...










